BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 8
• 9
• 10
• 11
• 14
• 15
• 16
• 17
• 18
• 21
• 22
• 23
• 24
• 25
• 28
• 29
• 30

• CeloNova BioSciences: New Micro-Bland Embolization Technique with Embozene(TM) Microspheres to Be Presented at the International Medical Conference in Lisbon, Portugal

  September 17, 2009

   · 

  1 min read
• Genetown

  Boston Scientific Corporation Announces Schedule of Events at TCT Conference

  September 17, 2009

   · 

  4 min read
• Drug Development

  Intarcia Therapeutics, Inc. Commences Enrollment of ITCA 650 Phase 2 Study in Type 2 Diabetes

  September 17, 2009

   · 

  1 min read
• Business

  Aethlon Medical Announces Annual Meeting Results

  September 17, 2009

   · 

  2 min read
• FDA

  YM BioSciences Reports NIMOTUZUMAB Approved for Marketing in Mexico

  September 17, 2009

   · 

  5 min read
• Biotech Beach

  Orexigen Therapeutics, Inc. to Speak at UBS Global Life Sciences Conference

  September 17, 2009

   · 

  1 min read
• Policy

  SafeBridge Consultants, Inc. Announces “Potent Compound Safety Certification” Approval of Novasep – Le Mans (Seripharm), Inc.

  September 17, 2009

   · 

  1 min read
• Policy

  Novasep Gains SafeBridge(R) “Potent Compound Safety Certification” for its Le Mans Facility

  September 17, 2009

   · 

  3 min read
• Policy

  Appeals Court Rules in Favor of Prometheus Laboratories Inc., Upholds the Patentability of Its Claims for Methods of Thiopurine Metabolite Testing

  September 17, 2009

   · 

  1 min read
• BioMidwest

  Angeion Corporation to Present at Wall Street Analyst Conference on Sept. 29

  September 17, 2009

   · 

  1 min read